Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-12-19
1993-10-19
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514824, 546339, A01N 4358, C07D21118
Patent
active
052545490
ABSTRACT:
Pharmaceutically-active BHT-omega pyridyl ethers of the formula selected from BHT-omega-pyridyl ether compounds of the formula: ##STR1## wherein m=1,3
REFERENCES:
patent: 4745120 (1988-05-01), Wess et al.
Svedmyr et al., "The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man", Clinical Pharmacology and Therapeutics 10, 559-570 (1969).
Gold Markus R.
Jarglis Panayiotis
Junglas Heinz
Leimner Juergen H.
Peteri Dezsoe
Covington Raymond
Hueschen Gordon W.
Ivy C. Warren
Merz & Co. GmbH & Co.
LandOfFree
New BHT ether compounds and their use as hypolipidemic and antia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New BHT ether compounds and their use as hypolipidemic and antia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New BHT ether compounds and their use as hypolipidemic and antia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1351817